UCLA Stem Cell Institute receives $3.75-million training grant from state

September 13, 2005

The UCLA Institute for Stem Cell Biology and Medicine (ISCBM) today received a three-year, $3.75-million grant - the largest awarded - from the state to train young scientists to conduct stem cell research.

UCLA's stem cell institute received the full amount of funding requested from the California Institute of Regenerative Medicine (CIRM), formed to oversee and fund stem cell research after voters in November overwhelming passed Proposition 71, the California Stem Cell Research and Cures Initiative. The state's Independent Citizens' Oversight Committee (ICOC), at a meeting in Sacramento, voted on and awarded the first stem cell research grants today.

UCLA stem cell institute officials said the money will help prepare the next generation of scientists who will conduct this leading-edge research.

"The aim of our program is to train basic scientists, engineers and physicians to become leaders in stem cell research," said Dr. Owen Witte, director of the UCLA stem cell institute, a professor of microbiology, immunology and molecular genetics and a Howard Hughes Medical Institute investigator. "A distinctive feature of UCLA's program is that these scientists will be trained from a multidisciplinary perspective."

The ISCBM will train 16 pre-doctoral, post-doctoral and clinical research scholars. Each will be offered various training options, including working with faculty who are leaders in cell and molecular biology, gene medicine, cell-based therapies and organ transplantation. Witte said the training program also will accommodate those interested in the social, legal, ethical or policy aspects of stem cell research.

"This will benefit the people of California by providing high-quality training in the scientific, clinical, social and ethical aspects of stem cell research to the scientists and clinicians who will be developing the future therapies in this rapidly emerging field," said Judith C. Gasson, ISCBM co-director and the director of UCLA's Jonsson Cancer Center.

The ISCBM training grant application received high marks, winning 94 out of a possible 100 points. The institute's research focus includes HIV/AIDS, cancer, neurological disorders, bone and cardiac disease as well as metabolic disorders such as diabetes.

Pending lawsuits could postpone the funding process, although California officials have indicated that the state will provide CIRM with the funding to cover the first round of grants.
-end-


University of California - Los Angeles

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.